Critical Care Diagnostics also known as point of care are the approved tests that are done near to the patient and provides quick result. The self-testing or over the counter test are also comes under critical care diagnostics. The pathology labs require certain time to provide results depends upon type of test, while critical care tests are the sophisticated test which provides result earlier to detect the disease for better treatment plan.
Critical care diagnostics provides quick diagnostics tests to the patient and where the results can be obtained immediately, while the pathology labs requires hours or sometime days to provide results. The critical care diagnostics includes cancer biomarker test, cardiac markers diagnostics, blood glucose testing, pregnancy testing, blood gas and electrolyte analysis, drugs of abuse, urine stripe testing, food pathogens screening, cholesterol screening, haemoglobin diagnostics and infectious disease testing. The critical care diagnostics are used in hospitals, research centres, clinical laboratories as well as home. These diagnostic tests are cost effective and provides appropriate and rapid diagnosis. These test are used for diagnosis of life threatening diseases occurring in patients.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2542
Critical Care Diagnostics Market: Drivers and Restraints
The Critical Care Diagnostics Market is expected to grow exponentially during the estimated period. The rising awareness about these test among physicians and patients and its associated benefits, increasing geriatric population, increasing prevalence of chronic disease like diabetes, heart disease, cancer will drive the market of critical care diagnostics in forecast period. However, the increasing cost of molecular diagnostics and less technological adoption in some developing countries may affect the growth of market. The critical care diagnostics test are easy to use and provides results and minutes. Theses test also provides mobile connectivity and hand-held system.
Critical Care Diagnostics Market: Segmentation
The global Critical Care Diagnostics Market is segmented on the basis of types of product, by mode of prescription, by End User, and regional presence.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2542
Segmentation based on Type of Product:
- Glucose monitoring kits
- Cardiometabolic monitoring kits
- Infectious Disease testing kits
- Coagulation monitoring kits
- Cancer markers testing kit
- Hematology testing kits
- Pregnancy and fertility testing kits
- Cholesterol test strips
- Drugs-Of-Abuse testing kits
- Fecal Occult testing kits
- Other critical care diagnostics testing kits
Segmentation based on Prescription Mode:
- Prescription-Based Testing Kits
- OTC Testing Kits Market
Segmentation based on End User:
- Ambulatory surgical centers
- Research Laboratories
Segmentation based on Distribution Channel:
- North America
- Latin America
- Western Europe
- Eastern Europe
- sia Pacific Excluding Japan
- The Middle East and Africa
Critical Care Diagnostics Market: Overview
The market of critical care diagnostics is segmented as by type of product of product, mode of prescription, by end user and geographically. The product type includes type of kits for various type of disease such as blood glucose test, cancer biomarker test, infectious disease such as HIV, STDs, hepatitis, respiratory infections, influenza testing kits etc. some of critical care diagnostics test are prescription base and some are Over the counter tests. The test like biomarker test, infectious disease test, hematology test etc. are prescription test. These test are prescribed by physician to detect the cause of disease and other factors. Test like blood glucose test, pregnancy test are OTC tests. These test are done at home by patient himself to monitor and to check the level of disease states and other things.
Critical Care Diagnostics Market: Regional Overview
Geographically, the global Critical Care Diagnostics Market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, Middle East and Africa
North America is expected to be the most lucrative market for critical care diagnostics owing to the presence more sophisticated instruments and technology in the region. The product awareness among the people of Europe is high and evolution of more physician’s office labs and this will fuel the market of critical care diagnostics in the region. The large presence of geriatric population, improving health care service due to positive support of government to provide treatment in rural regions, increasing prevalence of chronic disease such as hypertension, obesity, diabetes are the key factor responsible for growth of critical care diagnostics in Asia pacific. The increasing healthcare expenditure in Japan will drive the market growth in the country. The epidemiology and mortality due to severe disease like cancer, heart disease is more in the Latin America due to less facilities available in the country. The insurance plan by government of region will help in the critical care diagnostics market.
Critical Care Diagnostics Market: Key Players
Some of the major players operating in the market for Critical Care Diagnostics Market are Abbott Laboratories, Beckman Coulter, Inc., Beckman Coulter, Inc., Roche Diagnostics, Becton Dickinson & Co., Bio-Rad Laboratories, Nanomix Inx., Sysmex Corporation, Nova Biomedical, Siemens AG, Biosensors Japan etc. In 2015, stat profile prime, the blood gas analyzer, new generation product of Nova Biomedical got U.S. FDA approval for point of care diagnosis. In 2016, Abbott laboratories acquires Alere, the leader in point of care diagnostics.